Piers Patten

[UK Chronic Lymphocytic Leukaemia (CLL) Forum @UkCllforum]

Here it is. Prof Hillmen presenting FLAIR results at #ASH2023.
MRD guided I-V therapy in CLL leads to an OS benefit vs FCR in young-fit patients.
Congratulations to all investigators and thanks to all patients who have taken part.
Two words: practice changing.

[Piers Patten @piers_patten]

Great research about the microenvironment of breast cancer out today

[Irshad Lab @IrshadLab_]

Delighted to have our deep dive into understanding the #tumourmicroenvironment of high-risk chemotherapy resistant breast cancers published in @CCR_AACR today!!
@KCLcancer_pharm @ICR_London
@CRUKresearch
https://t.co/LJdn3Ks9ux
https://t.co/aQlpdnvD3G

[Blood Cancer UK @bloodcancer_uk]

5/ Great to see this highlighted in a letter from @piers_patten in today's @thetimes.

We will continue working with the media to try and raise awareness of this important issue. You can help us reach more people by sharing our posts - please retweet and help us spread the word.

[Piers Patten @piers_patten]

@bloodcancer_uk This is the paper: https://t.co/ZTxoMd8RQ1

[Blood Cancer Alliance @BloodCancerA]

We’ve today written to the Joint Committee on Vaccination and Immunisation (JCVI) calling for a review of vaccine timings for blood cancer patients.

We’ve also written to @MattHancock and @DHSCgovuk calling for an extension to #shielding guidance until more is known.

[Piers Patten @piers_patten]

@bloodcancer_uk https://t.co/1Kd1e7NCV6

[Piers Patten @piers_patten]

@BloodCancerA @bloodcancer_uk The initial findings can be found here: https://t.co/1Kd1e7NCV6

[Blood Cancer UK @bloodcancer_uk]

Following this morning's headlines that new research shows "Cancer patients 'lack same protection' after first Covid jab", we speak to Dr Piers Patten, a clinical haematologist from Kings College Hospital and one of the researchers behind the study, to find out more.

[Blood Cancer UK @bloodcancer_uk]

1/ People with blood cancer will be concerned by this news. We have been worried about how much protection the vaccines will give people with blood cancer because vaccines do not usually work as well for people with compromised immune systems.

[Blood Cancer UK @bloodcancer_uk]

3/ It’s now essential to monitor people with blood cancer when they have the #vaccine to understand this, and we now want to see those who live with people with blood cancer to be prioritised for vaccination to try and protect people with the disease as much as possible.

[Piers Patten @piers_patten]

@bloodcancer_uk Couldn’t agree more

[Piers Patten @piers_patten]

https://t.co/1lU27antPw

[Piers Patten @piers_patten]

New publication today- implications for our haematology patients both for the second wave and vaccines

[Antonio Pagliuca @ProfBMT]

Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients: Cancer Cell. Poor responses in the haematology cohort. We need to develop more data in the vaccine studies https://t.co/9AFGAwhNNw

[Piers Patten @piers_patten]

@ProfBMT Potentially lots of significance of these findings for patients with B cell malignancies which were the main ones we studied- their responses to Covid and what to do about vaccines

[Piers Patten @piers_patten]

@CwynKate @DrChrisPFox @KuhnlAndrea Shows what can be done on a virtual platform! More attendees than ever- great to see.

[Piers Patten @piers_patten]

@graham74GC See quite a lot of respiratory tract infiltration but can not recall effusions as such

[Piers Patten @piers_patten]

@graham74GC US patients now have other options to ibrutinib- easy then to switch to the best new available drugs. Side effect profile not bad.